Search PubMed⌕ Search

Biomedical subjects

Bernard Lobel

Publications and source records attributed to Bernard Lobel.

39 records · Page 3Linked to original sources

Renal cell carcinoma in young adults: incidence, disease outcome and review of the literature.

OBJECTIVE: To study the incidence, clinical presentation and pathological prognostic factors affecting disease outcome of RCC in young adults less than 40 years old. METHODS: The charts o medical records of 400 patients treated surgically for RCC between January 1984 and December 1999 were reviewed. 29 (7.25%) patients were under 40. We used ANOVA regression and Chisquare (Fisher exact test) to assess the prognostic value of the quantitative and qualitative variables, respectively. Estimation of the survival distributions were calculated according to Kaplan-Meier method and compared with Log rank test. Multivariate analysis of the entire population utilizing Cox models was performed. RESULTS: The most common histological cell type was clear cell carcinoma, found in 20 (69%) patients. At a median follow-up of 80 months, 20 (69%) patients were disease free and 9 (31%) died of the disease. Incidental discovery (p = 0.05), tumor stage (p = 0.043), grade (p = 0.011), lymphatic invasion (p < 0.0001) metastasis (p = 0.003), adrenal invasion (p = 0.024), and renal vein invasion (p < 0.0001) were associated with prognosis (Kaplan-Meier). When comparing patients less than 40 years vs. older than 40 years, we found significant differences in histology type (clear cell carcinoma 69% vs. 91%; p = 0.0001), and tumor stage at presentation (pT2 = 34.5% vs. 17.3%; p = 0.04) (pT3 = 20.7% vs. 42%; p = 0.03). Disease free survival was not significantly different between the two groups (69% vs. 65.7%; Log rank test p = 0.4). CONCLUSION: Although rare, RCC in young adults seems to follow a course similar to the disease seen in older patients. Among the prognostic factors studied incidental discovery, pathological stage of the tumor and grade, were associated with survival. Stage at presentation was different between the two populations however survival was not affected by age.

Adenocarcinoma↗

[Renal cell carcinoma before the age of 40: prognostic factors].

OBJECTIVE: To study the prognostic value of tumour diameter, TNM stage, Führman's nuclear grade and CD44 adhesion molecule expression in renal cell carcinoma (RCC) before the age of 40 years. MATERIAL AND METHODS: Nineteen patients under the age of 40 (12 males and 7 females; mean age 30.8 years), undergoing total nephrectomy for RCC were included in this study. Tumour diameter, TNM 1997 stage, and Führman's nuclear grade were defined for each tumour. Standard CD44 adhesion molecule (CD44H) expression was evaluated semiquantitatively by immunohistochemistry on each tumour. The prognostic value of the various variables was determined by Mann-Whitney and Chi-square tests and survival analysis was performed by the Kaplan-Meier method. RESULTS: Six patients (31.5%) died from their cancer with a mean follow-up of 81.4 months. Mean tumour diameter was 9 +/- 4.5 cm. Tumours were Führman I/II in 4 cases, Führman III/IV in 15 cases, T1/T2 in 14 cases and T3/T4 in 5 cases. CD44H expression was high (> or = 20%) in 9 cases (47.3%). The prognostic factors identified in this study were: tumour stage (p = 0.01), grade (p = 0.04), venous extension (p = 0.001) and CD44H overexpression (p = 0.003). CONCLUSION: Prognostic factors of renal cancer in patients under the age of 40 years do not appear to be different from those of older patients. The prognostic factors identified in this study must be validated by multicentre studies based on larger populations.

Adult↗

[Peri-prostatic nerve block at the level of the apex versus intrarectal lidocaine gel].

INTRODUCTION: After a review of the contradictory results of studies concerning periprostatic nerve block, the authors decided to prospectively evaluate the efficacy of periprostatic nerve block in the apex compared to the use of endorectal lidocaine gel. METHODS: From January 2001 to January 2002, 110 patients underwent prostatic biopsies. Patients were randomized to receive 10 cc of 2% lidocaine gel in the endorectal (group 1), or 10 cc of 1% lidocaine solution injected into the apex to induce bilateral periprostatic nerve block (group 2). Pain was evaluated by a 10-point linear visual analogue pain scale (VAS), and a 5-point digital visual scale (DVS). RESULTS: 96 patients were included in the study: 43 in group 1 and 53 in group 2. The mean pain score on the VAS was 2.76 +/- 1.69 and 1.73 +/- 1.26 for groups 1 and 2, respectively (p = 0.001). The DVS score was 2.26 +/- 0.82 and 1.62 +/- 0.56 for groups 1 and 2, respectively (p < 0.001). No significant difference was observed for mean age (p = 0.348), prostatic volume (p = 0.899), PSA level (p = 0.932) and complications between the two groups. The number of biopsies per patient was significantly higher in group 2 (p = 0.006), with significantly lower pain scores on each of the 2 scales. CONCLUSIONS: Apical periprostatic nerve block ensured better pain control during transrectal prostate biopsy, compared to the use of endorectal lidocaine gel, with no increase in the complication rate.

Administration, Rectal↗